Filing Details
- Accession Number:
- 0001562180-22-007177
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-10-12 18:50:15
- Reporting Period:
- 2022-10-07
- Accepted Time:
- 2022-10-12 18:50:15
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1404123 | 1Life Healthcare Inc | ONEM | Services-Offices & Clinics Of Doctors Of Medicine (8011) | 760707204 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1642829 | Dan Amir Rubin | C/O 1Life Healthcare, Inc. One Embarcadero Center, Suite 1900 San Francisco CA 94111 | Chair, Ceo And President | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2022-10-07 | 1,128,882 | $4.01 | 1,228,630 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2022-10-07 | 242,235 | $11.56 | 1,470,865 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2022-10-07 | 1,371,117 | $17.03 | 99,748 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Options (Right to buy) | Disposition | 2022-10-07 | 1,128,882 | $0.00 | 1,128,882 | $4.01 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2022-10-07 | 242,235 | $0.00 | 242,235 | $11.56 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2027-09-13 | No | 4 | M | Direct | |
| 2,064,765 | 2029-11-20 | No | 4 | M | Direct |
Footnotes
- The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan and were conducted by the reporting person for tax and estate planning purposes. The reporting person has adopted Rule 10b5-1 plans in the past and has adopted this Rule 10b5-1 plan in the ordinary course. The trading plans and their parameters do not reflect the reporting person's views on the closing of the pending, previously announced, merger or the prospects of the Company's business after the closing.
- This transaction was executed in multiple trades at prices ranging from $16.95 to $17.085. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- The shares subject to the option vested as follows: 20% of the shares subject to the option vested on the first anniversary of the vesting commencement date; and 1/60th of the shares subject to the option vested monthly thereafter over the following four years, subject to the reporting person's continuous service as of each such date.
- The shares subject to the option vest as follows: 63% of the shares subject to the option vest ratably on a monthly basis from the vesting commencement date through August 2023; 25% of the shares subject to the option vest ratably on a monthly basis from September 2023 to August 2024; and the remaining 12% of the shares subject to the option vest ratably on a monthly basis from September 2024 to August 2025, subject to the reporting person's continuous service as of each such date.
Billionaire Hedge Funds
